Shenyang Syndy Chemistry Institute

Shenyang Xindi Pharmaceutical Co., Ltd. is mainly engaged in the research, development and production of raw materials. The company passed the GMP certification again in 2009. Xindi Chemical is mainly engaged in the research and development of chemical drug synthesis technology and functional chemical synthesis technology. It has built relatively complete facilities from small-scale trials to pilot tests to mature-scale industrial production. The main products produced are chlorpheniramine maleate, brompheniramine maleate, and dextrorotatory chlorpheniramine maleate DMF, which have been registered in Japan and passed the J-GMP audit. The product quality meets the CP2010/BP2008/USP32/JP15/EP6.0 standards. The products have been adopted by many manufacturers at home and abroad and have passed the audits of many suppliers.